EP1479300B1 — Amino acid powder and process for producing the same
Assigned to Ajinomoto Co Inc · Expires 2009-10-21 · 17y expired
What this patent protects
[Object] To provide a dry powder of amino acids being excellent in meltability in mouth and solubility and a process for producing the same. [Means for Resolution] A process for producing a powder of amino acids that is a process for producing a powder by spray drying an aqueous …
USPTO Abstract
[Object] To provide a dry powder of amino acids being excellent in meltability in mouth and solubility and a process for producing the same. [Means for Resolution] A process for producing a powder of amino acids that is a process for producing a powder by spray drying an aqueous solution containing amino acids characterized in that the aqueous solution containing amino acids is spray dried in the state of fine droplets in the presence of trehalose to give a powder having an average grain size of from 0.1 to 15 µm; and a process for producing a powder of amino acids characterized in that dry granulation is performed during or after spray drying to give a powder having an average grain size of from 20 to 1000 µm.
Drugs covered by this patent
- Emend (APREPITANT) · Merck & Co.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.